CD44s regulates the TGF-β-mediated mesenchymal phenotype and is associated with poor prognosis in patients with hepatocellular carcinoma

Kosuke Mima, Hirohisa Okabe, Takatsugu Ishimoto, Hiromitsu Hayashi, Shigeki Nakagawa, Hideyuki Kuroki, Masayuki Watanabe, Toru Beppu, Mayumi Tamada, Osamu Nagano, Hideyuki Saya, Hideo Baba

研究成果: Article

101 引用 (Scopus)

抄録

The prognosis for individuals diagnosed with hepatocellular carcinoma (HCC) remains poor because of the high frequency of invasive tumor growth, intrahepatic spread, and extrahepatic metastasis. Here, we investigated the role of the standard isoform of CD44 (CD44s), a major adhesion molecule of the extracellular matrix and a cancer stem cell marker, in the TGF-β-mediated mesenchymal phenotype of HCC. We found that CD44s was the dominant form of CD44 mRNA expressed in HCC cells. Overexpression of CD44s promoted tumor invasiveness and increased the expression of vimentin, a mesenchymal marker, in HCC cells. Loss of CD44s abrogated these changes. Also in the setting of CD44s overexpression, treatment with TGF-β1 induced the mesenchymal phenotype of HCC cells, which was characterized by low E-cadherin and high vimentin expression. Loss of CD44s inhibited TGF-β-mediated vimentin expression, mesenchymal spindle-like morphology, and tumor invasiveness. Clinically, overexpression of CD44s was associated with low expression of E-cadherin, high expression of vimentin, a high percentage of phospho-Smad2-positive nuclei, and poor prognosis in HCC patients, including reduced disease-free and overall survival. Together, our findings suggest that CD44s plays a critical role in the TGF-β-mediated mesenchymal phenotype and therefore represents a potential therapeutic target for HCC.

元の言語English
ページ(範囲)3414-3423
ページ数10
ジャーナルCancer Research
72
発行部数13
DOI
出版物ステータスPublished - 2012 7 1

Fingerprint

Hepatocellular Carcinoma
Phenotype
Vimentin
Cadherins
Neoplasms
Neoplastic Stem Cells
Disease-Free Survival
Extracellular Matrix
Protein Isoforms
Neoplasm Metastasis
Messenger RNA
Therapeutics
Growth

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

これを引用

CD44s regulates the TGF-β-mediated mesenchymal phenotype and is associated with poor prognosis in patients with hepatocellular carcinoma. / Mima, Kosuke; Okabe, Hirohisa; Ishimoto, Takatsugu; Hayashi, Hiromitsu; Nakagawa, Shigeki; Kuroki, Hideyuki; Watanabe, Masayuki; Beppu, Toru; Tamada, Mayumi; Nagano, Osamu; Saya, Hideyuki; Baba, Hideo.

:: Cancer Research, 巻 72, 番号 13, 01.07.2012, p. 3414-3423.

研究成果: Article

Mima, K, Okabe, H, Ishimoto, T, Hayashi, H, Nakagawa, S, Kuroki, H, Watanabe, M, Beppu, T, Tamada, M, Nagano, O, Saya, H & Baba, H 2012, 'CD44s regulates the TGF-β-mediated mesenchymal phenotype and is associated with poor prognosis in patients with hepatocellular carcinoma', Cancer Research, 巻. 72, 番号 13, pp. 3414-3423. https://doi.org/10.1158/0008-5472.CAN-12-0299
Mima, Kosuke ; Okabe, Hirohisa ; Ishimoto, Takatsugu ; Hayashi, Hiromitsu ; Nakagawa, Shigeki ; Kuroki, Hideyuki ; Watanabe, Masayuki ; Beppu, Toru ; Tamada, Mayumi ; Nagano, Osamu ; Saya, Hideyuki ; Baba, Hideo. / CD44s regulates the TGF-β-mediated mesenchymal phenotype and is associated with poor prognosis in patients with hepatocellular carcinoma. :: Cancer Research. 2012 ; 巻 72, 番号 13. pp. 3414-3423.
@article{f83e9464cd8c4ca6ac6f7f4d6d58126a,
title = "CD44s regulates the TGF-β-mediated mesenchymal phenotype and is associated with poor prognosis in patients with hepatocellular carcinoma",
abstract = "The prognosis for individuals diagnosed with hepatocellular carcinoma (HCC) remains poor because of the high frequency of invasive tumor growth, intrahepatic spread, and extrahepatic metastasis. Here, we investigated the role of the standard isoform of CD44 (CD44s), a major adhesion molecule of the extracellular matrix and a cancer stem cell marker, in the TGF-β-mediated mesenchymal phenotype of HCC. We found that CD44s was the dominant form of CD44 mRNA expressed in HCC cells. Overexpression of CD44s promoted tumor invasiveness and increased the expression of vimentin, a mesenchymal marker, in HCC cells. Loss of CD44s abrogated these changes. Also in the setting of CD44s overexpression, treatment with TGF-β1 induced the mesenchymal phenotype of HCC cells, which was characterized by low E-cadherin and high vimentin expression. Loss of CD44s inhibited TGF-β-mediated vimentin expression, mesenchymal spindle-like morphology, and tumor invasiveness. Clinically, overexpression of CD44s was associated with low expression of E-cadherin, high expression of vimentin, a high percentage of phospho-Smad2-positive nuclei, and poor prognosis in HCC patients, including reduced disease-free and overall survival. Together, our findings suggest that CD44s plays a critical role in the TGF-β-mediated mesenchymal phenotype and therefore represents a potential therapeutic target for HCC.",
author = "Kosuke Mima and Hirohisa Okabe and Takatsugu Ishimoto and Hiromitsu Hayashi and Shigeki Nakagawa and Hideyuki Kuroki and Masayuki Watanabe and Toru Beppu and Mayumi Tamada and Osamu Nagano and Hideyuki Saya and Hideo Baba",
year = "2012",
month = "7",
day = "1",
doi = "10.1158/0008-5472.CAN-12-0299",
language = "English",
volume = "72",
pages = "3414--3423",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "13",

}

TY - JOUR

T1 - CD44s regulates the TGF-β-mediated mesenchymal phenotype and is associated with poor prognosis in patients with hepatocellular carcinoma

AU - Mima, Kosuke

AU - Okabe, Hirohisa

AU - Ishimoto, Takatsugu

AU - Hayashi, Hiromitsu

AU - Nakagawa, Shigeki

AU - Kuroki, Hideyuki

AU - Watanabe, Masayuki

AU - Beppu, Toru

AU - Tamada, Mayumi

AU - Nagano, Osamu

AU - Saya, Hideyuki

AU - Baba, Hideo

PY - 2012/7/1

Y1 - 2012/7/1

N2 - The prognosis for individuals diagnosed with hepatocellular carcinoma (HCC) remains poor because of the high frequency of invasive tumor growth, intrahepatic spread, and extrahepatic metastasis. Here, we investigated the role of the standard isoform of CD44 (CD44s), a major adhesion molecule of the extracellular matrix and a cancer stem cell marker, in the TGF-β-mediated mesenchymal phenotype of HCC. We found that CD44s was the dominant form of CD44 mRNA expressed in HCC cells. Overexpression of CD44s promoted tumor invasiveness and increased the expression of vimentin, a mesenchymal marker, in HCC cells. Loss of CD44s abrogated these changes. Also in the setting of CD44s overexpression, treatment with TGF-β1 induced the mesenchymal phenotype of HCC cells, which was characterized by low E-cadherin and high vimentin expression. Loss of CD44s inhibited TGF-β-mediated vimentin expression, mesenchymal spindle-like morphology, and tumor invasiveness. Clinically, overexpression of CD44s was associated with low expression of E-cadherin, high expression of vimentin, a high percentage of phospho-Smad2-positive nuclei, and poor prognosis in HCC patients, including reduced disease-free and overall survival. Together, our findings suggest that CD44s plays a critical role in the TGF-β-mediated mesenchymal phenotype and therefore represents a potential therapeutic target for HCC.

AB - The prognosis for individuals diagnosed with hepatocellular carcinoma (HCC) remains poor because of the high frequency of invasive tumor growth, intrahepatic spread, and extrahepatic metastasis. Here, we investigated the role of the standard isoform of CD44 (CD44s), a major adhesion molecule of the extracellular matrix and a cancer stem cell marker, in the TGF-β-mediated mesenchymal phenotype of HCC. We found that CD44s was the dominant form of CD44 mRNA expressed in HCC cells. Overexpression of CD44s promoted tumor invasiveness and increased the expression of vimentin, a mesenchymal marker, in HCC cells. Loss of CD44s abrogated these changes. Also in the setting of CD44s overexpression, treatment with TGF-β1 induced the mesenchymal phenotype of HCC cells, which was characterized by low E-cadherin and high vimentin expression. Loss of CD44s inhibited TGF-β-mediated vimentin expression, mesenchymal spindle-like morphology, and tumor invasiveness. Clinically, overexpression of CD44s was associated with low expression of E-cadherin, high expression of vimentin, a high percentage of phospho-Smad2-positive nuclei, and poor prognosis in HCC patients, including reduced disease-free and overall survival. Together, our findings suggest that CD44s plays a critical role in the TGF-β-mediated mesenchymal phenotype and therefore represents a potential therapeutic target for HCC.

UR - http://www.scopus.com/inward/record.url?scp=84863603551&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863603551&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-12-0299

DO - 10.1158/0008-5472.CAN-12-0299

M3 - Article

C2 - 22552294

AN - SCOPUS:84863603551

VL - 72

SP - 3414

EP - 3423

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 13

ER -